172 related articles for article (PubMed ID: 38396350)
1. Safety and potential usefulness of sequential intracoronary acetylcholine and ergonovine administration for spasm provocation testing.
Kinoshita Y; Saito Y; Kikuta Y; Sato K; Taniguchi M; Goto K; Takebayashi H; Haruta S; Kobayashi Y
Ther Adv Cardiovasc Dis; 2024; 18():17539447241233168. PubMed ID: 38396350
[TBL] [Abstract][Full Text] [Related]
2. Induction of coronary artery spasm by two pharmacological agents: comparison between intracoronary injection of acetylcholine and ergonovine.
Sueda S; Kohno H; Fukuda H; Ochi N; Kawada H; Hayashi Y; Uraoka T
Coron Artery Dis; 2003 Sep; 14(6):451-7. PubMed ID: 12966266
[TBL] [Abstract][Full Text] [Related]
3. Clinical impact of selective spasm provocation tests: comparisons between acetylcholine and ergonovine in 1508 examinations.
Sueda S; Kohno H; Fukuda H; Ochi N; Kawada H; Hayashi Y; Uraoka T
Coron Artery Dis; 2004 Dec; 15(8):491-7. PubMed ID: 15585990
[TBL] [Abstract][Full Text] [Related]
4. New combined spasm provocation test in patients with rest angina: intracoronary injection of acetylcholine after intracoronary administration of ergonovine.
Sueda S; Ochi T; Yano K; Mineoi K; Kondou T; Ochi N; Hayashi Y; Kukita H; Matsuda S; Kawada H; Tsuruoka T; Uraoka T
Jpn Circ J; 2000 Aug; 64(8):559-65. PubMed ID: 10952150
[TBL] [Abstract][Full Text] [Related]
5. Pharmacological spasm provocation testing in 2500 patients: provoked spasm incidence, complications and cardiac events.
Sueda S
Heart Vessels; 2020 Oct; 35(10):1368-1377. PubMed ID: 32350639
[TBL] [Abstract][Full Text] [Related]
6. Omitting 50 μg of intracoronary acetylcholine injection in the left coronary artery during spasm provocation test.
Okuya Y; Saito Y; Kitahara H; Kobayashi Y
J Cardiol; 2024 Jan; 83(1):25-29. PubMed ID: 37541427
[TBL] [Abstract][Full Text] [Related]
7. Sequential spasm provocation tests might overcome a limitation of the standard spasm provocation tests.
Sueda S; Miyoshi T; Sasaki Y; Sakaue T; Habara H; Kohno H
Coron Artery Dis; 2015 Sep; 26(6):490-4. PubMed ID: 25974266
[TBL] [Abstract][Full Text] [Related]
8. Relation of Vasoreactivity in the Left and Right Coronary Arteries During Acetylcholine Spasm Provocation Testing.
Okuya Y; Saito Y; Kitahara H; Kobayashi Y
Am J Cardiol; 2024 May; 219():71-76. PubMed ID: 38522651
[TBL] [Abstract][Full Text] [Related]
9. Safety and optimal protocol of provocation test for diagnosis of multivessel coronary spasm.
Sueda S; Miyoshi T; Sasaki Y; Sakaue T; Habara H; Kohno H
Heart Vessels; 2016 Feb; 31(2):137-42. PubMed ID: 25366987
[TBL] [Abstract][Full Text] [Related]
10. Vasospastic Angina Diagnosed by the Spasm Provocation Test with the Combined Use of the Acetylcholine and Ergonovine Provocation Tests.
Matsumura M; Oshita C; Fujii Y; Ueda T; Teragawa H
Intern Med; 2019 Aug; 58(16):2377-2381. PubMed ID: 31118393
[TBL] [Abstract][Full Text] [Related]
11. Differential incidence and morphology of provoked spasm between intracoronary acetylcholine and ergonovine testing: recommendation of supplementary use.
Sueda S; Fujimoto K; Sasaki Y; Sakaue T; Yoshii T; Habara H; Kohno H
Heart Vessels; 2019 May; 34(5):745-754. PubMed ID: 30474702
[TBL] [Abstract][Full Text] [Related]
12. Gender differences in sensitivity of acetylcholine and ergonovine to coronary spasm provocation test.
Sueda S; Miyoshi T; Sasaki Y; Sakaue T; Habara H; Kohno H
Heart Vessels; 2016 Mar; 31(3):322-9. PubMed ID: 25539623
[TBL] [Abstract][Full Text] [Related]
13. Intracoronary Acetylcholine Provocation Testing - Omission of the 20-µg Dose Is Feasible in Patients Without Coronary Artery Spasm in the Other Coronary Artery.
Saito Y; Kitahara H; Shoji T; Tokimasa S; Nakayama T; Sugimoto K; Fujimoto Y; Kobayashi Y
Circ J; 2016 Jul; 80(8):1820-3. PubMed ID: 27350015
[TBL] [Abstract][Full Text] [Related]
14. Safety of Provocative Testing With Intracoronary Acetylcholine and Implications for Standard Protocols.
Takahashi T; Samuels BA; Li W; Parikh MA; Wei J; Moses JW; Fearon WF; Henry TD; Tremmel JA; Kobayashi Y;
J Am Coll Cardiol; 2022 Jun; 79(24):2367-2378. PubMed ID: 35710187
[TBL] [Abstract][Full Text] [Related]
15. Feasibility and safety of outpatient cardiac catheterization with intracoronary acetylcholine provocation test.
Saito Y; Kitahara H; Shoji T; Tokimasa S; Nakayama T; Sugimoto K; Fujimoto Y; Kobayashi Y
Heart Vessels; 2018 Aug; 33(8):846-852. PubMed ID: 29435640
[TBL] [Abstract][Full Text] [Related]
16. Maximal acetylcholine dose of 200 μg into the left coronary artery as a spasm provocation test: comparison with 100 μg of acetylcholine.
Sueda S; Kohno H; Miyoshi T; Sakaue T; Sasaki Y; Habara H
Heart Vessels; 2015 Nov; 30(6):771-8. PubMed ID: 25179297
[TBL] [Abstract][Full Text] [Related]
17. Feasibility of omitting provocation test with 50 μg of acetylcholine in left coronary artery.
Saito Y; Kitahara H; Shoji T; Tokimasa S; Nakayama T; Sugimoto K; Fujimoto Y; Kobayashi Y
Heart Vessels; 2017 Jun; 32(6):685-689. PubMed ID: 27873006
[TBL] [Abstract][Full Text] [Related]
18. Overview of complications during pharmacological spasm provocation tests.
Sueda S; Kohno H
J Cardiol; 2016 Jul; 68(1):1-6. PubMed ID: 27234219
[TBL] [Abstract][Full Text] [Related]
19. Bronchial Asthma and Rest Angina: Is It Safe to Perform Acetylcholine Spasm Provocation Tests in These Patients?
Sueda S
Intern Med; 2020 Dec; 59(24):3117-3122. PubMed ID: 32788543
[TBL] [Abstract][Full Text] [Related]
20. The effect of intracoronary administration of ergonovine on the contralateral coronary artery in a provocation test for the diagnosis of variant angina.
Kim JH; Kim C; Kim J; Park JS; Lee HW; Choi JH; Lee HC; Cha KS; Hong TJ; Oh JH
Acta Cardiol; 2014 Dec; 69(6):628-34. PubMed ID: 25643433
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
